World Models

General Catalyst

Check: Not applicable. Hirsh leads Percepta, an operating/transformation company, rather than a General Catalyst investment team. Founders seeking GC capital should contact an actual GC investor; enterprises seeking embedded AI transformation can contact Percepta.

Hirsh's operating thesis is that enterprise AI fails when organizations bolt point solutions onto legacy workflows or stop at pilots. Percepta embeds engineers, researchers and product managers inside critical institutions, combining frontier intelligence, proprietary data, domain trust and workforce adoption to redesign operations. The focus is production transformation in healthcare, government, manufacturing and finance—not venture selection or personal check writing.

Khosla Ventures

Check: No personal check range is published. Khosla's firm-level Seed and Main Funds span technical experiments through later financings; historical seed commentary cited roughly $1M–$2M. Nicole's additional Capital Formation role should not be read as a disclosed personal check authority.

Nicole backs frontier AI across infrastructure, enterprise, consumer, defense, and biology. Her scientific training in cancer and viral immunology gives her a mechanistic lens for AI–biology convergence, while her founder experience provides a capital-efficient consumer and commercialization perspective. Her named investments—Medal/General Intuition, Highlight, Cellular Intelligence, and Vero—signal interest in world models and embodied intelligence, consumer/enterprise software, biological intelligence, and defense applications.